Evidence map›Paper›PMID 29669681›Full record

ArticleDeutsches Arzteblatt international2018

The Diagnosis and Treatment of Functional Dyspepsia.

Ahmed Madisch, Viola Andresen, Paul Enck, Joachim Labenz, Thomas Frieling, Michael Schemann

Abstract read
In one paragraph

Article in Deutsches Arzteblatt international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 5 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 5 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. First regional consensus on the management ofWorld journal of gastroenterology · 2025
    Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Ahmed MadischDepartment of Gastroenterology, Interventional Endoscopy, Diabetology, and Acute Geriatrics, KRH Hospital Siloah, Hanover
Viola AndresenDepartment of Medicine, Israelite Hospital, Hamburg
Paul EnckInternal Medicine VI: Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen
Joachim LabenzDepartment of Medicine, Diakonie Hospital Jung- Stilling, Siegen
Thomas FrielingDepartment of Gastroenterology, Helios Hospital Krefeld, Krefeld
Michael SchemannChair of Human Biology, TU Munich, Freising
Diakonie Klinikum Jung-Stilling · DEHelios Klinikum Krefeld · DEKlinikum Region Hannover · DEOspedale Israelitico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFunctional dyspepsia (FD) is one of the more common functional disorders, with a prevalence of 10-20%. It affectsthe gastrointestinal tract.

methodsThis article is based on publications retrieved by a selective search of PubMed, with special attention to controlled trials, guidelines, and reviews.

resultsTypical dyspeptic symptoms in functional dyspepsia include epigastric pain, sensations of pressure and fullness, nausea, and early subjective satiety. The etiology of the disorder is heterogeneous and multifactorial. Contributory causes include motility disturbances, visceral hypersensitivity, elevated mucosal permeability, and disturbances of the autonomic and enteric nervous system. There is as yet no causally directed treatment for functional dyspepsia. Its treatment should begin with intensive patient education regarding the benign nature of the disorder and with the establishment of a therapeutic pact for long-term care. Given the absence of a causally directed treatment, drugs to treat functional dyspepsia should be given for no more than 8-12 weeks. Proton-pump inhibitors, phytotherapeutic drugs, and Helicobacter pylori eradication are evidence-based interventions. For intractable cases, tricyclic antidepressants and psychotherapy are further effective treatment options.

conclusionThe impaired quality of life of patients with functional dyspepsia implies the need for definitive establishment of the diagnosis, followed by symptom-oriented treatment for the duration of the symptomatic interval.

Indexed as

DyspepsiaHelicobacter InfectionsHelicobacter pyloriHumansProton Pump InhibitorsQuality of LifeTreatment OutcomeProton Pump Inhibitors

Identifiers

PMID29669681
PMCPMC5938438
OpenAlexW2791770394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.